Research and analysis

Veterinary Antimicrobial Resistance and Sales Surveillance 2022

This UK VARSS report provides the details of UK veterinary antibiotic resistance and sales surveillance.

Documents

UK-VARSS Report 2022 Highlights

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

UK-VARSS Report 2022

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

UK-VARSS Report 2022 Supplementary Material 1

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

UK-VARSS Report 2022 Supplementary Material 2

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

UK-VARSS 2022 GOV slides

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

UK-VARSS 2022 Highlights

Details

The UK-VARSS 2022 Report presents veterinary antibiotic sales, usage and resistance data from the UK.

The UK-VARSS 2022 Supplementary Material documents provide further details including supplementary data and details of the methodologies used.

The UK-VARSS 2022 Highlights Report summarises key facts from the main report.

Your feedback is requested

Help us to improve the UK-VARSS report, now in its 10th year by providing your feedback through this 3 minute survey.

Antibiotic sales data

Veterinary pharmaceutical companies submit data annually to the Veterinary Medicines Directorate (VMD) on their previous year’s sales of antibiotics authorised for use in animals. The VMD uses the data provided to calculate the volume of active antibiotic ingredient sold.

Sales data are used as an estimate for antibiotic use. However, as not all antibiotics sold will be used, sales figures are generally an overestimate. In addition, many antibiotics are authorised for use in multiple animal species, so it is not possible to determine from sales data how much is used per sector or species. This highlights the importance of collecting antibiotic use data.

Antibiotic use data

The VMD is working in partnership with key food-producing animal sectors to develop, facilitate and coordinate antibiotic use collection systems.

Antibiotic use refers to the amount of antibiotics purchased, prescribed and/or administered. Producers, feed companies and veterinary practice sales records provided the antibiotic use data presented in the UK-VARSS report.

UK-VARSS 2022 presents use data from 90% or more of the meat poultry, laying hen, pig, gamebird, salmon and trout sectors. Available antibiotic use data from a sub-section of the ruminant sector is also included.

Monitoring of antibiotic resistance

The VMD monitors antibiotic resistance through two programmes: harmonised monitoring, which is a UK-wide, representative programme conducted on animals entering the food chain, and a clinical surveillance programme in England and Wales, which relies on the voluntary submission of diagnostic samples by farmers and veterinary surgeons.

Harmonised monitoring involves the collection of samples from healthy livestock at slaughter. Samples are tested for the presence of antibiotic resistant bacteria. The bacteria of interest are those which can potentially transfer between animals and humans (zoonotic organisms). This includes bacteria which are common causes of food poisoning such as Salmonella and Escherichia coli.

The clinical surveillance programme involves the collection of clinical samples that have been submitted to government and partner laboratories by a farmer or veterinary surgeon for diagnostic purposes. Any bacteria identified, including those which may cause disease in animals (veterinary pathogens), are tested for antibiotic resistance. Clinical data is also provided by laboratories in Scotland and Northern Ireland. The clinical surveillance data will be published in early 2024.

You can find previous UK-VARSS reports on the collection page.

Updates to this page

Published 1 November 2023
Last updated 24 October 2024 + show all updates
  1. Change notice: The multi-drug resistance definition has been updated within clinical surveillance in all documents.

  2. Updated to include Chapter 4 - Clinical surveillance of antibiotic resistance to all documents. Also, link to feedback survey.

  3. First published.

Sign up for emails or print this page